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Ethnopharmacological relevance: Lychnophora passerina (Asteraceae), popularly known as “arnica,” is used
to treat inﬂammation, pain, rheumatism, contusions, bruises and insect bites in Brazilian traditional
medicine.
Materials and methods: The anti-inﬂammatory activity of crude ethanolic extract of aerial parts of L.
passerina and its ethyl acetate and methanolic fractions had their abilities to modulate the production of
NO, TNF- and IL-10 inﬂammatory mediators in LPS/IFN--stimulated J774.A1 macrophages evaluated.
Moreover, the crude ethanolic extract and derived fractions were also in vivo assayed by carrageenan-
induced paw oedema in mice.
Results: In vitro assays showed remarkable anti-inﬂammatory activity of L. passerina crude ethanolic
extract (EE) and its ethyl acetate (A) and methanolic (M) fractions, through the inhibition of produc-
tion of NO and TNF- inﬂammatory mediators and induction of production of IL-10 anti-inﬂammatory
cytokine. In vivo assays showed anti-inﬂammatory activity for EE 10% ointment, similar to the standard
drug diclofenac gel. The A and M fraction ointments 20% presented anti-inﬂammatory activity.
Conclusion: The results obtained showed that possible anti-inﬂammatory effects of EE and its A and M
fractions may be attributed to inhibition pro-inﬂammatory cytokines production, TNF- and NO and to
increased IL-10 production. EE, A andMointments showed topical in vivo anti-inﬂammatory activity. The
in vivo anti-inﬂammatory activity of EE of L. passerina may be related to synergistic effects of different
substances in the crudeextract. Therefore, traditional useof aerial parts of L. passerina in the inﬂammatory
cial tconditions could bebeneﬁ. Introduction
Inﬂammation is a natural host-defensive process of the innate
mmunity response. Bacterial andviral infection triggers the activa-
Abbreviations: A, ethyl acetate fraction; DMSO, dimethyl sulfoxide; EE,
thanolic extract; H, hexanic fraction; IL-10, interleukin-10; INF-, interferon-
; iNOS, inducible nitric oxide synthase; LPS, lipopolysaccharide; M, methanolic
raction; MTT, 3-(4,5-dimethyl-2-thiazyl)-2,5-diphenyl-2H-tetrazoliumbromide;
F-B, nuclear factor-kB; NO, nitric oxide; NOS, nitric oxide synthase; PGE2,
rostaglandin E2; RNA, ribonucleic acid; S.E.M., standard error of mean; TNF-,
umor necrosis factor-.
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Open access under the Elsevier OA license. o treat topical inﬂammatory conditions, as evidencedby thepresent study.
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tion of numerous immune cells such as macrophages, monocytes,
and neutrophils undergoing to cellular responses such as phago-
cytic uptake and production of inﬂammatory mediators, such as
nitric oxide (NO), prostaglandinE2 (PGE2) and tumornecrosis factor
(TNF)- (Gautam and Jachak, 2009; Yu et al., 2010). NO is produced
from l-arginine by the enzyme nitric oxide synthase (NOS) (Palmer
et al., 1988). Large amounts of NO are produced by the enzyme
inducible nitric oxide synthase (iNOS), enzyme involved in cellu-
lar overproduction of NO and active when a pathologic process
is present, like inﬂammation or cancer, and many other condi-
tions (Stichtenoth and Frolich, 1998). The TNF- cytokine plays a
crucial role in inﬂammation, stimulating the production of other
Open access under the Elsevier OA license. cytokines and pro-inﬂammatory mediators (Verma et al., 2010).
However, overproduction of TNF- is related to development and
progression of inﬂammatory process and autoimmune diseases
(Williams et al., 2007). Unlike NO and TNF-, the interleukin (IL)-
10 is the most important cytokine presenting anti-inﬂammatory
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roperties. It is produced by activated immune cells, mainly
onocytes/macrophages and regulates many different immune
ells functions. In monocytes/macrophages, IL-10 diminishes the
roduction of inﬂammatory mediators and inhibits antigen pre-
entation (Sabat et al., 2010).
Lychnophora (Asteraceae) is endemic to campo rupestre habitats
f Brazilian savanna (cerrado biome) and have a wide variety of
iological activities including anti-inﬂammatory, antinociceptive
nd trypanocidal activity (Chiari et al., 1996; Oliveira et al., 1996;
erraz Filha et al., 2006; Guzzo et al., 2008). The aerial parts of the
ychnophora species, including Lychnophora passerina, have been
sed in a folk medicine macerated in ethanol to treat inﬂammatory
nd pain conditions (Cerqueira et al., 1987).
Although the traditional use of Lychnophora species as
nti-inﬂammatory agents is supported by scientiﬁc evidence
Gobbo-Netoet al., 2005; Ferraz Filhaet al., 2006;Guzzoet al., 2008)
here are few studies of its action mechanism. We reported previ-
usly that the ethanolic extract from aerial parts of the L. passerina
xhibited in vivo topical anti-inﬂammatory activity (Guzzo et al.,
008). Based on these data, the objectives of the presentworkwere
o evaluate, whether the same ethanolic extract have the ability to
nhibit, in vitro, theproductionof theNOandTNF-and to stimulate
L-10 release from J774.A1 macrophages stimulated by LPS/IFN-.
n addition, the ethanolic extracts and its fractions were also in vivo
valuated, using the carrageenan-induced paw oedema methods
est in mice.
. Materials and methods
.1. Plant material
Aerial parts of L. passerina (Mart exDC.) Gardn were collected
n Diamantina, Minas Gerais, Brazil, in September 2000. The plant
otanical identiﬁcation was realized by Dr. Júlio A. Lombardi,
epartamento de Botânica, Instituto de Biociências de Rio Claro,
NESP, Rio Claro, SP, Brazil. A voucher specimen was deposited in
he Herbarium of Instituto de Ciências Exatas e Biológicas of Uni-
ersidade Federal de Ouro Preto – UFOP, under the number BHCB
3571.
.2. Preparation of plant extract and fractions
Aerial parts (1 kg) of L. passerina were air-dried, ground and
xtracted with ethanol by percolation, at room temperature,
or 14 days. The solvent was eliminated by evaporation under
educed pressure, resulting the dried crude ethanolic extract. The
thanolic extract (EE, 120.0 g) was submitted to ﬁltration col-
mn chromatography on silica gel, eluted with hexane, ethyl
cetate and methanol to yield the hexanic (H, 0.42 g), ethyl
cetate (A, 55.0 g) and methanolic (M, 59.0 g) fractions, respec-
ively.
.3. Cell line and culture conditions
J774A.1 murine macrophage cell line was kindly provided by
r. Affonso, L.C.C. (Laboratório de Imunoparasitologia – NUPEB
Universidade Federal de Ouro Preto, Minas Gerais, Brazil). The
ells were maintained in RPMI supplemented with 100U/ml of
enicillin, 2mM of l-glutamine, 100U/ml of penicillin G, 1mM of
odium pyruvate and 10% fetal bovine serum. Cells were grown at
7 ◦C in a humidiﬁed 5% CO2 atmosphere..4. Cell viability by MTT assay
To exclude the possible interference of the EE, A and
on cell viability the 3-(4,5-dimethyl-2-thiazyl)-2,5-diphenyl-pharmacology 135 (2011) 393–398
2H-tetrazoliumbromide (MTT) assay was performed. J774.A1
(2.5×105 cells/well) macrophages were plated in 96-well plates
and allowed to adhere at 37 ◦C in a 95% air and 5% CO2 atmo-
sphere for 2h. Thereafter, the medium was replaced with fresh
medium or medium containing increasing concentrations of the
EE, A and M dissolved in DMSO for 24h at 37 ◦C and 5% CO2
in humidiﬁed air. After 24h, MTT solution (dissolved in PBS)
was added (ﬁnal concentration of 0.5mg/ml) to each well and
incubated for 4h in the same conditions. The medium was care-
fully discarded, and 100l of sodium dodecyl sulfate 10% in
hydrochloric acid 10mM was added to each well to solubilize the
formazan. The optical density was measured at 550nm. The end
concentration of DMSO was adjusted to less than 0.1% for all treat-
ments.
2.5. NO inhibition assay
J774A.1 cells were seeded onto a 24-well culture plate at
density 2.5×105 cells per well with 500l of culture medium
and incubated for 2h. The cells were stimulated with LPS+ IFN-
(1g/ml +10UI/ml, respectively) for 1h before the treatment with
EE, A and M dissolved in DMSO at different non-cytotoxic concen-
trations (2.5–40g/ml) for 24h at 37 ◦C and 5% CO2 in humidiﬁed
air. After 24h, the presence of nitrite, a stable oxidized product
of nitric oxide (NO), was determined in cell culture media using
Griess reagent. Brieﬂy, 50l of supernatantwas removed and com-
bined with 100l of Griess reagent in a 96-well plate, followed by
incubation for 10min at room temperature and spectrophotomet-
ric measurement at 550nm using a microplate reader (Molecular
Devices) as described by Green et al. (1982) and Verma et al.
(2010). NO concentration was determined using comparison with
a sodium nitrite standard curve. The ﬁnal concentration of DMSO
was adjusted to less than 0.1% for all treatments. Dexamethasone
was used as a reference standard.
2.6. TNF-˛ inhibition assay and IL-10 stimulation assay
J774A.1 cells were seeded onto a 24-well culture plate at
density 2.5×105 cells per well with 500l of culture medium
and incubated for 2h. The cells were stimulated with LPS+ IFN-
(1g/ml +10UI/ml, respectively) for 1h before the treatment with
EE, A and M dissolved in DMSO at different non-cytotoxic concen-
trations (2.5–40g/ml) for 24h at 37 ◦C and 5% CO2 in humidiﬁed
air. After 24h, the supernatant was collected and used to estimate
the levels of TNF- and IL-10 by speciﬁc ELISA kits according to the
manufacturers’ instruction (ELISA kit, PeproTech, Brazil), respec-
tively. The ﬁnal concentration of DMSO was adjusted to less than
0.1% for all treatments. Dexamethasone was used as a reference
standard.
2.7. Preparation of ointments containing crude ethanolic extract
and its fractions
EE, A and M were solubilized in Tween-80, DMSO and distilled
water (1:1:8) and mixed with base ointment (lanoline/vaseline
70:30) for the 10% ﬁnal concentration.
2.8. Animals
For in vivoassayswereutilizedmale Swiss albinomice (30±5g),
supplied by Animal House of Universidade Federal de Ouro
Preto (UFOP). The animals received feed and water ad libitum
with light/dark period of 12h. The experimental protocols were
approved, under the number 2010/59, by UFOP Ethical Committee
of Animal Experimentation. The protocols were in accordance to
the Guide for the Care and Use of Laboratory Animals, published
Ethnopharmacology 135 (2011) 393–398 395
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Fig. 1. (A) Effect of the ethanolic extract (EE), (B) effect of acetyl acetate fraction
(A) and (C) effect of methanolic fraction (M) on NO production by LPS/IFN- stimu-
lated J774.A1 macrophages. The cells were stimulated with LPS (1g/ml) and IFN-
(10UI/ml) for 1h before the treatment with EE, A and M dissolved in DMSO atP. Capelari-Oliveira et al. / Journal of
y the US National Institute of Health (NIH Publication, revised in
985).
.9. Carrageenan-induced paw oedema assay
The in vivo anti-inﬂammatory activity was determined by
he carrageenan-induced paw oedema method in mice, accord-
ng to previously described (Winter et al., 1962). The 10% EE, A
nd M ointments (three groups) were topically applied on right
ind paws using a spatula, immediately after 0.1% carrageenan
Sigma–Aldrich) saline solution subplantar administration. Three
ore groups were established: (a) carrageenan, treated with base
intment, corresponding to 100% of inﬂammation (carrageenan
roup), (b) only needle introduction in the left paw, correspond-
ng to activity induced by mechanical perforation (control group),
nd (c) carrageenan treated with standard drug diclofenac gel
Cataﬂan® Emulgel–Novartis, 11.6mg/g). To ensure the ointment
ontact with paws bandages were used. To measure oedema vari-
tion a digital caliper rule (Starret) was used. The paws were
easured before and 3h after carrageenan administration, with or
ithout treatments. Thepawoedemawas expressed inmillimeters
mm) and was calculated as the percentage of variation between
ero time and 3h after carrageenan.
.10. Statistical analysis
In vitro results were obtained from two independent exper-
ments in duplicate and are presented as mean± S.E.M. In vivo
esults were presented as means± S.E.M from experiments per-
ormed with 8 animals per group. Statistical signiﬁcance among
roups was determined by ANOVA followed by Bonferroni test
sing software PRISMA (GraphPad Software, Inc., San Diego, CA,
ersion 5.01). P-values≤0.05 were taken to indicate statistical sig-
iﬁcance.
. Results
L. passerina is used in the folk medicine as anti-inﬂammatory,
nalgesic and to treat rheumatism. In this study, the ethanol extract
nd its fractions were investigated for their in vitro and topical
n vivo anti-inﬂammatory activity.
.1. Effects of crude ethanolic extract and its fractions on cell
iability of J774.A1 macrophages
The viability of the J774.A1macrophages in the presence of EE, A
nd M were evaluated. The cytotoxicity evaluated to different con-
entrations of EE, A and M on the J774.A1 cells was negligible and
id not show statistic difference when compared to the control.
he exception occurred for the M fraction, since the concentra-
ion of 40g/ml showed cell viability lower than 90% (data not
hown). Thus, EE, A and M fractions were in vitro assayed for anti-
nﬂammatory activity using concentrations lower than 40g/ml.
.2. Effects of crude ethanolic extract and its fractions on NO
roduction
To evaluate the inhibitory effects of the EE, A and M on NO pro-
uction by LPS/IFN- stimulated cells, they were treated with LPS
1g/ml) and IFN- (10UI/ml) in the presence or absence of the
E, A and M for 24h. The amount of nitrite, as an index of NO in
ulture medium, was measured with Griess reagent. Unstimulated
774.A1 cells secreted basal levels of NO, while LPS/IFN- stimu-
ation resulted in NO production increase. EE and A were able to
nhibit the NO production by LPS/IFN- stimulated J774.A1 cells in
concentration-dependent manner (Fig. 1A and B), at the higher
valuated concentrations: 20g/ml and 40g/ml for the EE, anddifferent non-cytotoxic concentrations (2.5–40g/ml) for 24h. Supernatants were
collected and nitrite (NO) concentrationwas determined by Griess reagent. Data are
represented as mean± S.E.M. values. *P<0.05, **P<0.01 and ***P<0.001 compared
with LPS/IFN--stimulated macrophages alone.
10g/ml, 20g/mland40g/ml for theA.Mwasnotable to reduce
the NO levels, in any evaluated concentration (Fig. 1C).
3.3. Effects of crude ethanolic extract and its fractions on TNF-˛
production
To determine the inhibitory effects of crude EE and A and
M fractions of L. passerina, on LPS/IFN--stimulated TNF- pro-
duction, J774.A1 macrophages were treated with LPS (1g/ml)
and IFN- (10UI/ml) in the presence or absence of different con-
centrations of EE, A and M. The macrophages stimulated only
with LPS/IFN- exhibited an appreciable increase of TNF- lev-
els, while in the absence of any stimulus the cells secreted basal
levels of TNF- (Fig. 2). The strong inhibition of TNF- pro-
duction was observed for almost all evaluated concentrations of
EE (Fig. 2A) and M (Fig. 2C) and a lower effect was observed
for the A fraction (Fig. 2B). The EE at 5, 10, 20 and 40g/ml
decreased the LPS/IFN--stimulated TNF- production. TheM frac-
tion was also active at the same concentrations. The A fraction
396 P. Capelari-Oliveira et al. / Journal of Ethnopharmacology 135 (2011) 393–398
Fig. 2. (A) Effect of the ethanolic extract (EE), (B) effect of acetyl acetate fraction (A)
and (C) effect of methanolic fraction (M) on TNF- production by LPS/IFN- stimu-
lated J774.A1 macrophages. The cells were stimulated with LPS (1g/ml) and IFN-
(10UI/ml) for 1h before the treatment with EE, A and M dissolved in DMSO at dif-
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Fig. 3. (A) Effect of the ethanolic extract (EE), (B) effect of acetyl acetate fraction (A)
and (C) effect of methanolic fraction (M) on IL-10 production by LPS/IFN- stimu-
lated J774.A1 macrophages. The cells were stimulated with LPS (1g/ml) and IFN-
(10UI/ml) for 1h before the treatment with EE, A and M dissolved in DMSO at dif-
ferent non-cytotoxic concentrations (2.5–40g/ml) for 24h. The supernatantswere
collected and IL-10 concentrationwasdeterminedby speciﬁc ELISAkit. Data are rep-
The EE ointment at 10% signiﬁcantly reduced the carrageenan-erent non-cytotoxic concentrations (2.5–40g/ml) for 24h. The supernatantswere
ollected and TNF- concentration was determined by speciﬁc ELISA kit. Data are
epresented as mean± S.E.M. values. *P<0.05, **P<0.01 and ***P<0.001 compared
ith LPS/IFN--stimulated macrophages alone.
howed better inhibitory activity at concentrations of 2.5g/ml
nd 5g/ml.
.4. Effects of crude ethanolic extract and its fractions on IL-10
roduction
The effects of EE and A and M of L. passerina on IL-10 produc-
ion were investigated in J774.A1 macrophages stimulated with
PS (1g/ml) and IFN- (10UI/ml) in the presence or absence
f different concentrations. The cells stimulated with LPS/IFN-
exhibited an increase of IL-10 production, while unstimulated
774.A1 cells secreted signiﬁcant smaller basal levels of IL-10
Fig. 3). EE increased the LPS/IFN--induced IL-10 production in
lmost all evaluated concentrations, except for 20g/ml. A signif-
cantly increased the IL-10 folds, mainly at 2.5g/ml, 5g/ml andresented asmean± S.E.M. values. *P<0.05, **P<0.01 and ***P<0.001 comparedwith
LPS/IFN--stimulated macrophages alone.
10g/ml. M did not induce alteration of IL-10 production in all
evaluated concentrations (Fig. 3C).
3.5. Effects of crude ethanolic extract and its fractions on
carrageenan-induced paw oedemainduced paw oedema (Table 1). The A and M ointments at 20%,
signiﬁcantly reduced the oedema. Diclofenac gel, used as stan-
dard anti-inﬂammatory drug, was able to reduce signiﬁcantly the
oedema. Moreover, the anti-inﬂammatory activity of EE ointment
at 10%was similar to diclofenac gel.
P. Capelari-Oliveira et al. / Journal of Ethno
Table 1
Effect of topically appliedointmentsof L. passerinaethanolic extract (EE) and its ethyl
acetate (A) and methanolic (M) fractions evaluated using carrageenan-induced paw
oedema.
Treatment after carrageenan Swelling thickness (%)
Control condition (without carrageenan) 2.7 ± 0.35***
Base ointment 29.9 ± 1.86
Diclofenac gel 6.6 ± 1.22***
EE 10% 12.6 ± 2.61***
M 20% 20.1 ± 1.60*
A 20% 16.9 ± 1.27***
Results represent themean± S.E.M. of the percentage variation. *P<0.05; **P<0.01;
*
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activity of EE of L. passerina may be related to synergistic effects of**P<0.001, when compared to the group treated with base ointment (ANOVA
ollowed Bonferroni’s test). The measurements were taken before and 3h after
dministration of carrageenan.
. Discussion
The present study assessed the anti-inﬂammatory potential in
itro of EE in J774.A1 macrophages stimulated by LPS (1g/ml)
nd IFN- (10UI/ml). The assays quantiﬁed the release of pro-
nﬂammatory mediators NO and TNF- and the IL-10 production,
n anti-inﬂammatory cytokine. The NO is produced by activated
acrophages as a result of various stimuli, including TNF-, IFN-
nd LPS, and it contributes to the pathological process of differ-
nt acute and chronic inﬂammatory conditions (Nathan, 1992). The
NF- also plays an important role in inﬂammation and may act
n the monocytes and macrophages by an autocrine activity to
ncrease diverse functional responses and to induce an over expres-
ion of inﬂammatory mediators. (Baugh and Bucala, 2001). IL-10
s an anti-inﬂammatory cytokine, well known for its inhibitory
ffects on TNF- and inﬂammatory reactions. Its main activity is
o inhibit the cytokine production by macrophages (Bortesi et al.,
009).
EE, A and M fractions presented inhibitory activity on NO and
NF- production, by LPS/IFN--induced J774.A1 macrophages.
oreover, EEwasable to signiﬁcantly increase the IL-10production
y J774.A1 macrophages activated with LPS/IFN-, the model of
n vitro inﬂammation used in the presentwork. However, it is inter-
sting tonote that inhibitionof TNF-productionand the induction
f IL-10 production by A decreased at the highest concentrations
valuated. The lack or decreasing of plant extracts activity at higher
oncentrations is also frequently cited in the literature (Punturee
t al., 2004; Hammer et al., 2008). Concerning to IL-10, this may
e due to post-transcriptional effects of metabolites present in
E, since it is known that production of this anti-inﬂammatory
ytokine may be regulated by post-transcriptional mechanisms in
acrophages (Nemeth et al., 2005). Adittionally, M strongly inhib-
ted the TNF- production, but showed a weak inhibition of NO
roductionandweakactivity on the IL-10productionbyLPS/IFN--
timulated macrophages. The signiﬁcant basal secretion of TNF-,
bserved in the inhibition of production assay for this cytokine, has
lso been reported in other studies that showed greater produc-
ion of this pro-inﬂammatory mediator by LPS/IFN--stimulated
774.A1 macrophages and by the same cells stimulated only with
PS (Herath et al., 2003; Fan et al., 2010).
Previous phytochemical investigations of the aerial parts of L.
asserina resulted in the isolation of the triterpenoids, sesquiter-
enes, including sesquiterpene lactones, steroid and of the
avonoids (Bohlmann et al., 1981; Oliveira et al., 1996; Chicaro
t al., 2004).
Several terpenoids have inhibitory properties on the produc-
ion of inﬂammatory cytokines (Bremner and Heinrich, 2002;
íos, 2010) and among the terpenoids present in plant kingdom,
he sesquiterpene lactones are specially produced and accu-
ulated by species of Lychnophora genus, as well as by otherpharmacology 135 (2011) 393–398 397
species of Asteraceae family (Bohlmann and Jakupovic, 1990). The
sesquiterpene lactones goyazensolide and 15-desoxigoyazensolide
showed pharmacological activities, including anti-inﬂammatory
and trypanocidal activity (Chiari et al., 1996; Oliveira et al., 1996;
Rüngeler et al., 1999). Several sesquiterpene lactones showed anti-
inﬂammatory activity in cellular model of inﬂammation (Lyb et al.,
1998; Rüngeler et al., 1999; Koo et al., 2001) and the action mecha-
nism proposed has been the suppression of nuclear factor-kappa
B (NF-кB) activation (Palladino et al., 2003; Ríos, 2010), which
regulates the transcription of inﬂammatory cytokines and other
molecules involved in inﬂammation (Cho et al., 2009; Lu et al.,
2009). Thus, the inhibitory activity of NO and TNF- production
and induction of IL-10 production by A may be probably related to
sesquiterpene lactones and triterpenoids presences and inhibition
of the nuclear factor NF-B activity.
Some ﬂavonoids are able to inhibit TNF- production, the
iNOS expression and the NO production, as well as stimulation
of the IL-10 expression, effects that have been associated to NF-
B activity inhibition (Herath et al., 2003; Comalada et al., 2006;
Hämäläinen et al., 2007). However, in this study, M did not show
signiﬁcant activity on NO and IL-10 production, but inhibited the
TNF- secretion. Since TNF- is produced early in the inﬂam-
matory process (Jin et al., 2003; Hammer et al., 2008) and IL-10
is produced later (Jin et al., 2003; Jung et al., 2004), the polar
ﬂavonoids present in M can act at the initial phase diminishing
the production of pro-inﬂammatory cytokines, but was not able
to increase the secretion of cytokines that act in the late phase
of inﬂammation, such as the IL-10. EE inhibited NO and TNF-
 and increased the IL-10 production by LPS/IFN--stimulated
macrophages. The EE fractionation was able to concentrate more
active substances in the A fraction than in the M fraction, resulting
better activity to A fraction. The EE, characterized by presence of
terpenoids and ﬂavonoids, can exert immunomodulatory activity
by synergistic ways, resulting in a remarkable anti-inﬂammatory
activity.
Since the topical application of alcoholic macerates of aerial
parts of L. passerina is used in traditional medicine to treat
inﬂammation and pain, this route of administration was chosen
in order to evaluate the in vivo anti-inﬂammatory proper-
ties of EE, A and M. The in vivo anti-inﬂammatory activity
for EE at 10% and A and M at 20% ointments was observed.
These results conﬁrmed the anti-inﬂammatory effects observed
in vitro.
Therefore, the remarkable in vivo activity observed for EEmaybe
attributed to synergism of several bioactive molecules. The activ-
ity of different substances on different inﬂammation targets, as
well as the possibility to improve the bioavailability of molecules,
may result in a grater activity of crude extracts (Ji et al., 2009),
rather than semi puriﬁed fractions. There is growing evidence
showing that the medicinal plants may exhibit synergistic com-
binations (Phillipson, 2003; Gilani and Rahman, 2005; Ma et al.,
2009; Wagner and Ulrich-Merzenich, 2009; Graz et al., 2010).
5. Conclusion
The results obtained showed that possible anti-inﬂammatory
effects of EE and its A and M fractions may be attributed to inhibi-
tion pro-inﬂammatory cytokines production, TNF- and NO and to
increased IL-10 production. EE, A and M ointments showed topical
in vivo anti-inﬂammatory activity. The in vivo anti-inﬂammatorydifferent substances in the crude extract. Therefore, traditional use
of aerial parts of L. passerina in the inﬂammatory conditions could
be beneﬁcial to treat topical inﬂammatory conditions, as evidenced
by the present study.
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